Search Results 771-780 of 19225 for hemoglobin

1. A Study of MK-1026 in Patients with Selected Hematologic Malignancies - Mayo Clinic

   Hemoglobin (Hgb) ≥ 8.0 g/dL, stable for ≥ 1 week. For men and women of child-bearing potential, willing to use adequate contraception (e.g., latex condom ...

2. Fuchs Clinical Trials - Mayo Clinic Research

   ... hemoglobin A1c (HbA1c), and skin advanced glycation endproducts (AGE) and ... . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo ...

3. A Phase 2, Multicenter, Randomized Study of AP26113 - Mayo Clinic

   Hemoglobin ≥10 g/dL. Have Eastern Cooperative Oncology Group (ECOG) performance status ≤2. Have normal QT interval on screening electrocardiogram (ECG) ...

4. A Study to Perform Synovial Biopsies on Patients with Rheumatoid Arthritis - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; Platelets ≥ 100 x 109 cells/L. Able to adhere to the study visit schedule, understand and comply with other protocol requirements ...

5. Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

   Marrow: Peripheral blood leukocyte count (WBC) < 3000/mm3, absolute neutrophil count ≤ 1500/mm3, platelets < 75000/mm3, or hemoglobin < 10 gm/dL; Hepatic ...

6. A Study of Levosimendan in Pulmonary Hypertension (PH) with Heart Failure (HF) and Preserved Left Ventricular Ejection Fraction (pEF) Patients - Mayo Clinic

   Hemoglobin < 80 g/L. Serum potassium < 3.0 mmol/L or > 5.5 mmol/L at baseline that is unresponsive to management . Participating Mayo Clinic locations. Study ...

7. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable). Creatinine clearance (CrCL) ...

8. Fuchs Dystrophy Clinical Trials - Mayo Clinic Research

   ... hemoglobin A1c (HbA1c), and skin advanced glycation endproducts (AGE) and ... . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo ...

9. A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™ Capsules in Patients With Advanced Solid Tumors - Mayo Clinic

   Hemoglobin ≥ 9 g/dL. Urinalysis: No clinically significant abnormalities. Acceptable coagulation status: PT ≤ 1.5 times institutional ULN;; PTT ≤ 1.5 ...

10. Stereotactic Body Radiation Therapy in Treating Patients with Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable); If liver metastases ...